摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-azabicyclo[5.3.0]decane | 5715-05-9

中文名称
——
中文别名
——
英文名称
1-azabicyclo[5.3.0]decane
英文别名
1-Azabicyclo<5.3.0>decane;azabicyclo<5.3.0>decane;octahydro-pyrrolo[1,2-a]azepine;Octahydro-pyrrolo[1,2-a]azepin;1-Aza-bicyclo<5.3.0>decan;1-Azabicyclo<5.3.0>decan;Octahydro-1H-pyrrolo[1,2-a]azepine;2,3,5,6,7,8,9,9a-octahydro-1H-pyrrolo[1,2-a]azepine
1-azabicyclo[5.3.0]decane化学式
CAS
5715-05-9
化学式
C9H17N
mdl
——
分子量
139.241
InChiKey
UCAVZTHZDCOEFH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    10
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    3.2
  • 氢给体数:
    0
  • 氢受体数:
    1

安全信息

  • 海关编码:
    2933990090

SDS

SDS:27817c203242a21fd91c03e21993adb3
查看

反应信息

  • 作为反应物:
    描述:
    1-azabicyclo[5.3.0]decane盐酸 作用下, 以 乙醚 为溶剂, 以76 %的产率得到octahydro-1H-pyrrolo[1,2-a]azepine,hydrochloride
    参考文献:
    名称:
    N,N-二苄基氨基乙腈的烷基化:从五元到七元含氮杂环体系
    摘要:
    介绍了几种生物碱和含氮化合物的合成,包括N -Boc-coniine ( 14b )、pyrrolizidine ( 1 )、δ-coniceine ( 2 ) 和 pyrrolo[1,2a ] azepine ( 3 )。通过金属化 α-氨基腈4和6a-c与具有所需尺寸和官能度的烷基碘进行烷基化,在相对于氮原子的 α 位置形成新的 C-C 键。在所有报告的案例中,吡咯烷环都是通过有利的 5-外四角在水性介质中形成的涉及伯氨基或仲氨基和末端 δ-离去基团的过程。相反,氮杂环庚烷环在作为首选非质子溶剂的N , N-二甲基甲酰胺 (DMF) 中通过未报道的 7-外四环化过程有效形成,该过程涉及亲核性更强的氨基钠和由饱和六碳原子承载的末端甲磺酸盐链单元。通过这种方式,我们无需繁琐的分离方法,就可以从廉价易得的材料中成功合成吡咯并[1,2 a ]氮杂环庚烷3和 2-丙基-氮杂环庚烷14c ,且收率高。
    DOI:
    10.1021/acs.joc.2c02795
  • 作为产物:
    描述:
    2-甲基吡咯啉 在 lithium aluminium tetrahydride 、 lithium diisopropyl amide 作用下, 以 四氢呋喃乙醚正己烷 为溶剂, 反应 18.75h, 生成 1-azabicyclo[5.3.0]decane
    参考文献:
    名称:
    吲哚并idine啶和喹oli嗪的新型合成
    摘要:
    通过2-甲基-1-吡咯啉或6-甲基-2,3,4,5-四氢吡啶与1,3-或1,4-二卤代烷烃的烷基化反应,开发了吲哚唑烷,喹喔啉和一些更高同系物的非常短的合成方法,然后还原中间亚胺盐,得到所需的1-氮杂双环[ m]。n .0]烷烃收率高。
    DOI:
    10.1016/s0040-4020(03)00375-2
点击查看最新优质反应信息

文献信息

  • [EN] PYRIDAZINONE DERIVATIVES AND USE THEREOF AS P2X7 RECEPTOR INHIBITORS<br/>[FR] DÉRIVÉS DE PYRIDAZINONE ET LEUR UTILISATION COMME INHIBITEURS DU RÉCEPTEUR P2X7
    申请人:NISSAN CHEMICAL IND LTD
    公开号:WO2009057827A1
    公开(公告)日:2009-05-07
    Novel pyridazinone compounds of formula (I), which inhibit the purinergic P2X7 receptor and are useful for prevention, therapy and improvement of inflammatory and immunological diseases.
    翻译结果为:新型的哒嗪酮化合物,其化学公式为(I),能够抑制嘌呤能P2X7受体,并对预防、治疗和改善炎症性和免疫性疾病有益。
  • (METH)ACRYLATE MANUFACTURING METHOD
    申请人:TOAGOSEI CO., LTD
    公开号:US20180118658A1
    公开(公告)日:2018-05-03
    The present invention provides a (meth)acrylate manufacturing method characterized in that when manufacturing a (meth) acrylate by an ester exchange reaction between an alcohol and a monofunctional (meth)acrylate using catalyst A and catalyst B together, contact treatment of the ester exchange reaction product with adsorbent C is performed. Catalyst A: One or more kinds of compounds selected from a group consisting of cyclic tertiary amines with an azabicyclo structure and salts or complexes thereof, amidine and salts or complexes thereof, compounds with a pyridine ring and salts or complexes thereof, phosphines and salts or complexes thereof, and compounds with a tertiary diamine structure and salts or complexes thereof. Catalyst B: One or more kinds of compounds selected from a group consisting of compounds comprising zinc. Adsorbent C: One or more kinds of compounds selected from a group consisting of oxides and hydroxides comprising at least one of magnesium, aluminum and silicon.
    本发明提供了一种(甲基)丙烯酸酯制备方法,其特征在于通过在使用催化剂A和催化剂B一起进行醇和单官能基(甲基)丙烯酸酯之间的酯交换反应制备(甲基)丙烯酸酯时,对酯交换反应产物进行与吸附剂C的接触处理。催化剂A:从含有氮杂双环结构的环状三级胺及其盐或络合物、胺嘧啶及其盐或络合物、含有吡啶环的化合物及其盐或络合物、膦及其盐或络合物、以及含有三级二胺结构的化合物及其盐或络合物中选择的一种或多种化合物。催化剂B:从含锌化合物中选择的一种或多种化合物。吸附剂C:从含有镁、铝和硅中至少一种的氧化物和氢氧化物中选择的一种或多种化合物。
  • MULTIFUNCTIONAL (METH)ACRYLATE MANUFACTURING METHOD
    申请人:TOAGOSEI CO., LTD.
    公开号:US20170204044A1
    公开(公告)日:2017-07-20
    [Problem] The purpose of the present invention is to obtain a multifunctional (meth)acrylate with good yield by an ester exchange reaction of a polyhydric alcohol such as pentaerythritol or dipentaerythritol with a monofunctional (meth)acrylate. [Solution] A multifunctional (meth)acrylate manufacturing method characterized in that when manufacturing a multifunctional (meth)acrylate by an ester exchange reaction of a polyhydric alcohol with a monofunctional (meth)acrylate, catalyst (A) and catalyst (B) are used together. Catalyst (A): One or more kinds of compounds selected from a group consisting of cyclic tertiary amines with an azabicyclo structure or salts or complexes thereof, amidines or salts or complexes thereof, and compounds with a pyridine ring or salts or complexes thereof. Catalyst (B): One or more kinds of compounds selected from a group consisting of zinc-containing compounds.
    [问题] 本发明的目的是通过多元醇(如戊三醇或二戊三醇)与单官能基(甲基)丙烯酸酯的酯交换反应,获得产率高的多功能(甲基)丙烯酸酯。[解决方案] 一种多功能(甲基)丙烯酸酯制备方法,其特征在于,在通过多元醇与单官能基(甲基)丙烯酸酯的酯交换反应制备多功能(甲基)丙烯酸酯时,同时使用催化剂(A)和催化剂(B)。催化剂(A):选自具有氮杂双环结构的环三胺或其盐或络合物、酰胺或其盐或络合物以及吡啶环或其盐或络合物组成的群中的一种或多种化合物。催化剂(B):选自含锌化合物组成的群中的一种或多种化合物。
  • METHOD FOR PRODUCING (METH)ACRYLATE
    申请人:TOAGOSEI CO., LTD.
    公开号:US20180105483A1
    公开(公告)日:2018-04-19
    A method for producing a (meth) acrylate comprises transesterification reaction of an alcohol and a monofunctional (meth) acrylate with catalysts in combination being cyclic tertiary amines having an azabicyclo structure and compounds containing zinc, separating a solid that contains the catalysts from a reaction product containing a (meth) acrylate, and producing a (meth) acrylate by transesterification reaction of an alcohol and a monofunctional (meth) acrylate, while using the recovered solid catalyst.
    生产(甲基)丙烯酸酯的方法包括使用具有氮杂双环结构的环状三级胺和含锌化合物作为催化剂,将醇和单官能团(甲基)丙烯酸酯进行酯交换反应,从含有催化剂的固体中分离出含有(甲基)丙烯酸酯的反应产物,然后通过将醇和单官能团(甲基)丙烯酸酯进行酯交换反应,并使用回收的固体催化剂来生产(甲基)丙烯酸酯。
  • USE OF SUBSTITUTED 1-(ARYL ETHYNYL)-, 1-(HETEROARYL ETHYNYL)-, 1-(HETEROCYCLYL ETHYNYL)- AND 1-(CYCLOALKENYL ETHYNYL)-CYCLOHEXANOLS AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS
    申请人:BAYER CROPSCIENCE AG
    公开号:US20150305334A1
    公开(公告)日:2015-10-29
    The invention relates to the use of substituted 1-(arylethynyl)-, 1-(heteroarylethynyl)-, 1-(heterocyclylethynyl)- and 1-(cycloalkenylethynyl)cyclohexanols or salts thereof where the radicals in the general formula (I) correspond to the definitions given in the description, for enhancing stress tolerance in plants to abiotic stress and/or for increasing plant yield.
    本发明涉及使用取代的1-(芳基乙炔基)-、1-(杂芳基乙炔基)-、1-(杂环基乙炔基)-和1-(环烯基乙炔基)环己醇或其盐,其中通式(I)中的基团与描述中给定的定义相对应,用于增强植物对非生物胁迫的耐受性和/或增加植物产量。
查看更多

同类化合物

环戊二烯并[4,5]氮杂卓并[2,1,7-cd]吡咯里嗪 吡咯并[1,2-a]氮杂-5-酮 六氢-1H-吡咯并[1,2-A]氮杂卓-5(6H)-酮 N,N-二甲基-3-(3-甲基-1,2,4,5-四氢氮杂卓并[4,5-b]吲哚-6-基)丙-1-胺 9-氟-1,2,3,4,5,6-六氢氮杂卓并[4,5-b]吲哚 7,8-二氢-5H-吡咯并[1,2-A]氮杂环庚烷-9(6H)-酮 6-叔-丁基3A-乙基八氢吡咯并[2,3-D]氮杂卓-3A,6(2H)-二甲酸基酯 6,7-二氢吡咯并[2,3-c]氮杂卓-4,8(1H,5H)-二酮 5H-吡咯并[1,2-a]氮杂卓-7-醇 5,9:7,11-二亚甲基-5H-吡咯并[1,2-a]吖壬英-3-羧酸,6,7,8,9,10,11-六氢-,甲基酯 4-(2-氨基-1H-咪唑-5-基)-2,3-二溴-6,7-二氢吡咯并[2,3-c]氮杂卓-8(1H)-酮 4-(2-氨基-1H-咪唑-4-基)-2,3-二溴-4,5,6,7-四氢吡咯并[2,3-c]氮杂卓-8(1H)-酮 4-(2-氨基-1,5-二氢-5-氧代-4H-咪唑-4-亚基)-4,5,6,7-四氢-吡咯并[2,3-c]氮杂卓-8(1H)-酮 3-苄基-1,2,3,4,5,6-六氢氮杂卓并[4,5-b]吲哚 3-(3,9-二甲基-1,2,4,5-四氢氮杂卓并[4,5-b]吲哚-6-基)-N,N-二甲基丙烷-1-胺 2H,3H-氧杂环丁烷并[3,2-d]吡咯并[1,2-a]氮杂卓 2-溴-6,7-二氢-1h,5h-吡咯并[2,3-c]氮杂烷-4,8-二酮 2,5-已炔二醇 2,3,4,5-四氢-N,N-二甲基-2-(3,4,5-三甲氧基苯甲酰基)-氮杂卓并(3,4-b)吲哚-10(1H)-丙胺 11-氧杂-3,10-二氮杂三环[7.2.1.03,7]十二碳-1,4,6,9-四烯 1,4,5,6,7,8-六氢吡咯并[3,2-b]氮杂卓 1,2,3,4,5,6-六氢氮杂环庚烷[4,3-B]吲哚盐酸盐 1,2,3,4,5,6-六氢-9-甲基氮杂卓并[4,5-b]吲哚 1,2,3,4,5,6-六氢-6-甲基氮杂革[4,5-b]吲哚盐酸盐 1,2,3,4,5,6-六氢-3-甲基氮杂卓并[4,5-b]吲哚 (1R*,2E,11S*)-2-(cyclohexylmethylene)-1-(phenylsilyl)methyloctahydropyrrolo[1,2-a]azepine (R)-2-(6,7,8,9-tetrahydro-5H-pyrrolo[1,2-a]azepin-9-yl)-acetaldehyde curvulamine (3aR,8aS)-tert-butyl octahydropyrrolo[3,4-d]azepine-2(1H)-carboxylate hydrochloride tert-butyl 6-(2-amino-2-oxoethyl)-1,4,5,6-tetrahydroazepino[4,5-b]indole-3(2H)-carboxylate 3-benzoyl-10-bromo-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 3-(tert-butyloxycarbonyl)-10-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 1,2,3,4,5,6-hexahydro-3-dimethylaminoethyl-5-hydroxymethylazepino[4,5-b]indole 1,2,3,4,5,6-hexahydro-3-dimethylaminoethyl-5-hydroxymethyl-6-methylazepino[4,5-b]indole (Z)-2,3,9,9a-tetrahydro-6,6-dimethyl-9-methylene-8-vinyl-1H-pyrrolo[1,2-a]azepin-5(6H)-one 2,3,4,5,6,7-hexahydro-1H-3a,8,13,13b-tetraazabenzo[b]cyclopenta[1,2,3-jk]fluorene 2,3,4,5,6,7-hexahydro-1H-3a,8,11,11b-tetraazacyclohepta[1,2,3-jk]fluorene 1-Benzyloxy-2-methoxy-7,8,9,10-tetrahydro-6H-azepino<1,2-a>indole-11-carbaldehyde 3-benzoyl-10-(2-propoxyphenyl)-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 2-phenyl-2,4,5,6-tetrahydro-1H-6-azabenzo[a]cyclohepta[cd]azulen-1-one 2-carbetoxy-3-(N,N-dimethyl)aminomethyleneamino-8-oxo-8H-4,5,6,7-tetrahydropyrrolo<2,3-c>azepine 3-benzoyl-10-[2-(trifluoromethyl)phenyl]-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 3-benzoyl-10-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 6-[2-(4-fluorophenyl)ethyl]-3,4,5,6-tetrahydroazepino[4,3-b]indol-1(2H)-one 5-(2-hydroxy-3-morpholin-4-yl-propyl)-3-methyl-4-oxo-1,4,5,6,7,8-hexahydro-pyrrolo[3,2-c]azepine-2-carbaldehyde 6-(2-phenylethyl)-3,4,5,6-tetrahydroazepino[4,3-b]indol-1(2H)-one 11-(tert-butyldimethylsilyloxy)-1-trimethylsilyl-3a,4,11,12-tetrahydro-3H-cyclopenta[5,6]azepine[1,2-a]indole-2-one tert-butyl 8,9-dichloro-6-[2-(2,3-dimethylanilino)-2-oxoethyl]-1,4,5,6-tetrahydroazepino[4,5-b]indole-3(2H)-carboxylate tert-butyl 9,10-dichloro-6-[2-(2,3-dimethylanilino)-2-oxoethyl]-1,4,5,6-tetrahydroazepino[4,5-b]indole-3(2H)-carboxylate tert-butyl (1R,4S)-1-(benzylcarbamoyl)-3-oxo-2-((S)-1-phenylethyl)-1,2,3,4,5,10-hexahydroazepino[3,4-b]indol-4-ylcarbamate